Positive predictive value of CEA and Ca19-9 as tumor markers for recurrent colorectal cancer in cases where conventional work-up fail to localize disease.

Yana Bocheva, Pavel Bochev

Abstract


Introduction: Routine surveillance of colorectal cancer includes serial measurements of CEA levels. Although not routinely indicated Ca 19-9 is also a tool for recurrence. When any of these serum markers is elevated during follow up, this could represent a recurrence. The management of elevated tumor marker levels include clinical exams, endoscopy and conventional imaging –ultrasound, CT, MRI.

Objective: To evaluate the positive predictive value of CEA and Ca19-9 as tumor markers for recurrent colorectal cancer in cases where conventional imaging and endoscopic studies fail to localize disease.

Materials and methods: A total of 75 patients with elevated CEA and/or Ca19-9 serum levels and negative endoscopic exam as well as negative abdominal CT and Chest X-ray were included in the study. CEA levels were tested in 50 patients. Ca 19-9 was tested in 65 patients. 34 of the patients had both markers tested. All patients underwent whole body 18F-FDG PET/CT. Patients with negative of equivocal PET scan were further followed up (10 to 24 months).

Results: Based on the reference standard – the results from PET/CT, if positive and the results from follow-up in cases of negative or equivocal scans, the positive predictive value of Ca 19-9 was 84% and that of CEA -83%. There was no significant difference in the PPV of Ca19-9 and CEA.

Conclusion: Elevated CEA and Ca 19-9 levels in patients under active surveillance after operation for colorectal cancer have high positive predictive value for recurrence, even in cases where conventional work-up – endoscopy and CT don’t localize disease.


Keywords


Colorectal cancer, CEA, Ca 19-9, FDG PET/CT

Full Text:

PDF

References


Abir,F.,Alva,S.,Longo,W.Audiso,R.,Virgo,KS.,Johnson,FE. (2006) The postoperative surveillance of patients with colon cancer and rectal cancer. Am J Surg,192(1):100-108

Del Villano,BC.,Brennan,S.,Brock,P.,Bucher,C.,Liu,V.,McClure,M.,Rake,B.,Space,S.,Westrick,B., Schoemaker,H.,Zurawski,VR Jr. (1983) Radioimmunometric assay for monoclonal antibody-defined tumor marker, CA19-9. Clinical Chemistry, 29;549-552

Diez,M.,Cerdán,FJ.,Pollán,M.,Maestro,ML.,Ortega,MD.,Martínez,S.,Moreno,G.,Balibrea,JL. (1994) Prognostic significance of preoperative serum CA 19-9 assay in patients with colorectal carcinoma. Anticancer Research,14: 2819-26

Duffy,MJ.,van Dalen,A.,Haglund,C.,Hansson,L.,Holinski-Feder,E.,Klapdor,R.,Lamerz,R.,Peltomaki,P., Sturgeon,C.,Topolcan,O. (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use . European Journal of cancer 43:1348-1360.

Figueredo,A.,Rumble,RB.,Maroun,J,Earle,CC,Cummings,B,McLeod,R.,Zuraw,L.,Zwaal,C. (2003) Follow-up of patients with curatively resected colorectal cancer: A practice guideline. BMC Cancer, 3:26

Fiocchi, F., Iotti,V., Ligabue,G., Malavasi,N., Luppi,G,, Bagni,B.,Torricelli,P. (2011) Role of carcinoembryonic antigen, magnetic resonance imaging, and positron emission tomography-computed tomography in the evaluation of patients with suspected local recurrence of colorectal cancer. Clinical Imaging, 35: 266–273

Grossmann,I.de Bock,GH.,Meershoek-Klein Kranenbarg,WM.,van de Velde,CJ.,Wiggers, T. (2007) Carcinoembryonic antigen (CEA) measurement during follow-up for rectal carcinoma is useful even if normal levels exist before surgery. A retrospective study of CEA values in the TME trial. European Journal of Surgical oncology.33(2):183-187

In Ja Park, Gye-Seog Choi, Soo Han Jun (2009) Prognostic Value of Serum Tumor Antigen CA19-9 After Curative Resection of Colorectal Cancer. Anticancer research, 29: 4303-4308

Jemal,A.,Bray,F.,Center,MM.,Ferlay,J.,Ward,E.,Forman,D.(2011) Global cancer statistics. Ca Cancer J Clin, 61:69-90

Kawamura,YJ.,Tokumitsu,A.,Mizokami,K.,Sasaki,J.,Tsujinaka,S.,Konishi,F.(2010)First Alert for Recurrence During Follow-up After Potentially Curative Resection for Colorectal Carcinoma: CA 19-9 Should Be Included in Surveillance Programs. Clinical Colorectal Cancer, 9(1):48-51

Kim B.J., Lee, K.T.,Moon, T.G. (2009) How do we interpret an elevated carbohydrate antigen 19-9 level in asymptomatic subjects? Digestive and Liver Disease,41: 364–369

Koprovski,H., Steplewski,Z.,Mitchell,K.,Herlin,M.,Fuhrer,P. (1979) Colorectal carcinoma antigen detected by hybridoma antibodies. Somatic Cell Genetics, 5:957-72/

Magnani, JL., Nilsson, B., Brockhaus, M., Zopf, D., Steplewski, Z., Koprowski, H., Ginsburg, V. (1982) A monoclonal antibody-defined antigen associated with gastrointestinal cancer in a ganglioside containing sialylated lacto N- fucopentaose II, J Biol Chem,257:14365-9

Metser, U., You,J., McSweeney,S., Freeman,M., Hendler,A. (2010) Assessment of Tumor Recurrence in Patients With Colorectal Cancer and Elevated Carcinoembryonic Antigen Level: FDG PET/CT Versus Contrast-Enhanced 64-MDCT of the Chest and Abdomen. American Journal of roentgenology, 194(3):766-71

NCCN clinical practice guidelines in oncology – Colon Cancer v.3/2015. Retrieved Aug, 6, 2015, from http://www.nccn.org/professionals/physician_gls/pdf/colon.pdf

NCCN clinical practice guidelines in oncology – Rectal Cancer v.3/2015. Retrieved Aug, 6, 2015, from http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf

Nicolini,A., Ferrari,P., Duffy,MJ., Antonelli,A., Rossi,G., Metelli,MR.,Fulceri,F.,Anselmi,L.,Conte,M., Berti,P., Miccoli,P.(2010)Intensive Risk-Adjusted Follow-up With the CEA,TPA, CA19.9, and CA72.4 Tumor Marker Panel and Abdominal Ultrasonography to Diagnose Operable Colorectal Cancer Recurrences. Archives of surgery,145(12):1177-83

Obrand,D.,Gordon,P. (1997) Incidence and pattern of recurrence following curative resection for colorectal carcinoma. Diseases of the colon and rectum, 40(1): 15-24

Renehan,AG.,Egger,M.,Saunders,MP.,O'Dwyer,ST. (2002) Impact on survival of intensive follow up after curative resection for colorectal cancer: systematic review and meta-analysis of randomised trials. BMJ, 324:813.

Tan, E., Gouvas, N., Nicholls, RJ., Ziprin, P., Xynos, E., Tekkis, PP. (2009). Diagnostic precision of carcinoembryonic antigenin the detection of recurrence of colorectal cancer . Surgical Oncology ,18: 15-24

Thomas L (1998). Clinical Laboratory Diagnostics; TH Books, Frankfurt/Main




DOI: http://dx.doi.org/10.12955/emhpj.v8i2.701

Refbacks

  • There are currently no refbacks.


Print ISSN 1804-5804, Online ISSN 1804-9702

(c) 2018 CBU,o.p.s.